Evidence map›Paper›PMID 33895166›Full record

ArticleGastroenterology2021

A Diffusion-like Process Accommodates New Crypts During Clonal Expansion in Human Colonic Epithelium.

Cora Olpe, Doran Khamis, Maria Chukanova, Nefeli Skoufou-Papoutsaki, Richard Kemp, Kate Marks, Cerys Tatton, Cecilia Lindskog, Anna Nicholson, Roxanne Brunton-Sim and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 2 countries.

Cora OlpeCancer Research-UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom; Wellcome Trust-Medical Research Council, Cambridge Stem Cell Institute, Cambridge, UK.
Doran KhamisMRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford, United Kingdom.
Maria ChukanovaCancer Research-UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom.
Nefeli Skoufou-PapoutsakiCancer Research-UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom; Wellcome Trust-Medical Research Council, Cambridge Stem Cell Institute, Cambridge, UK.
Richard KempCancer Research-UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom.
Kate MarksPathology and Data Analytics, St James's University Hospital, Leeds, United Kingdom.
Cerys TattonCancer Research-UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom.
Cecilia LindskogDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
Anna NicholsonCancer Research-UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom.
Roxanne Brunton-SimNorwich Research Park BioRepository, Norwich, United Kingdom.
Shalini MalhotraDepartment of Oncology, University of Cambridge, Cambridge, United Kingdom.
Rogier Ten HoopenDepartment of Oncology, University of Cambridge, Cambridge, United Kingdom.
Rachael StanleyNorwich Research Park BioRepository, Norwich, United Kingdom.
Douglas J WintonCancer Research-UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom; Wellcome Trust-Medical Research Council, Cambridge Stem Cell Institute, Cambridge, UK. Electronic address: doug.winton@cruk.cam.ac.uk.
Edward MorrisseyMRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford, United Kingdom. Electronic address: edward.morrissey@imm.ox.ac.uk.
Cancer Research UK · GBNorwich Research Park · GBUniversity of Cambridge · GBJohn Radcliffe Hospital · GBMedical Research Council · GBScience for Life Laboratory · SESt James's University Hospital · GBUniversity of Oxford · GB

Funding

Cancer Research UK A24456Medical Research Council MC_UU_12025Wellcome TrustWellcome Trust 109141/Z/15/Z
6 · The paper itself

Abstract

BACKGROUND &

aimsColorectal cancer (CRC) is thought to arise when the cumulative mutational burden within colonic crypts exceeds a certain threshold that leads to clonal expansion and ultimately neoplastic transformation. Therefore, quantification of the fixation and subsequent expansion of somatic mutations in normal epithelium is key to understanding colorectal cancer initiation. The aim of the present study was to determine how advantaged expansions can be accommodated in the human colon.

methodsImmunohistochemistry was used to visualize loss of the cancer driver KDM6A in formalin-fixed paraffin-embedded (FFPE) normal human colonic epithelium. Combining microscopy with neural network-based image analysis, we determined the frequencies of KDM6A-mutant crypts and fission/fusion intermediates as well as the spatial distribution of clones. Mathematical modeling then defined the dynamics of their fixation and expansion.

resultsInterpretation of the age-related behavior of KDM6A-negative clones revealed significant competitive advantage in intracrypt dynamics as well as a 5-fold increase in crypt fission rate. This was not accompanied by an increase in crypt fusion. Mathematical modeling of crypt spacing identifies evidence for a crypt diffusion process. We define the threshold fission rate at which diffusion fails to accommodate new crypts, which can be exceeded by KRAS activating mutations.

conclusionsAdvantaged gene mutations in KDM6A expand dramatically by crypt fission but not fusion. The crypt diffusion process enables accommodation of the additional crypts up to a threshold value, beyond which polyp growth may occur. The fission rate associated with KRAS mutations offers a potential explanation for KRAS-initiated polyps.

Indexed as

Cell ProliferationMutationAdolescentAdultAgedAged, 80 and overAge FactorsCell Transformation, NeoplasticColonic PolypsColorectal NeoplasmsDiffusionEpithelial CellsFemaleHistone DemethylasesHumansIntestinal MucosaHistone DemethylasesKDM6A protein, humanKRAS protein, humanProto-Oncogene Proteins p21(ras)Colorectal Cancer InitiationCrypt FissionCrypt FusionIntestinal Crypt

Identifiers

PMID33895166
PMCPMC8377717
OpenAlexW3153789104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.